Table 1 All-age cases and age-standardized incidence, prevalence, deaths, DALYs, YLDs, and YLLs rates in 2021 for liver cancer in China.

From: Long-term trends and future projections of liver cancer burden in China from 1990 to 2030

Measure

All-ages cases (95% UI)

Age-standardized rates per 100, 000 people (95% UI)

Total

Male

Female

Total

Male

Female

Incidence

196,637 (158,273, 243,558)

143,788 (108,927, 193,831)

52,848 (41,045, 67,026)

9.52 (7.72, 11.78)

14.34 (10.93, 19.18)

4.89 (3.82, 6.18)

Prevalence

265,539 (212,435, 331,149)

198,826 (150,846, 266,673)

66,713 (51,940, 84,332)

13.29 (10.75, 16.41)

20 (15.38, 26.47)

6.64 (5.19, 8.32)

Deaths

172,068 (139,621, 212,496)

122,463 (93,115, 164,816)

49,605 (38,617, 62,668)

8.35 (6.8, 10.29)

12.4 (9.46, 16.55)

4.57 (3.57, 5.76)

DALYs

4,890,023 (3,905,089, 6,124,599)

3,702,093 (2,805,347, 4,985,654)

1,187,930 (924,053, 1,513,173)

239.91 (191.98, 299.37)

368.19 (279.67, 490.95)

111.91 (87.16, 141.96)

YLDs

46,603 (31,434, 65,156)

34,142 (22,296, 50,853)

12,461 (8158, 17,953)

2.27 (1.53, 3.15)

3.4 (2.25, 5.04)

1.17 (0.77, 1.69)

YLLs

4,843,420 (3,867,971, 6,072,034)

3,667,951 (2,778,593, 4,930,847)

1,175,469 (913,934, 1,496,493)

237.63 (190.4, 296.93)

364.78 (277.17, 486.49)

110.74 (86.25, 140.35)

  1. DALYs disability-adjusted life-years, YLDs years lived with disability, YLLs years of life lost.